Hikal schedules Q4FY26 earnings conference call

Hikal Limited has announced it will hold an earnings conference call to discuss the financial and operational performance of the company for the quarter and financial year ended March 31, 2026. The call is scheduled for Wednesday, May 27, 2026, at 4:30 PM IST, pursuant to Regulation 30 of the SEBI Listing Regulations.

The conference call will feature key management personnel, including the Vice Chairman and Managing Director, the Chief Financial Officer, and Presidents of the Pharmaceuticals Business and Animal Health divisions. They will address the audited Standalone and Consolidated Financial Results for Q4 and FY26.

Conference Call Details

Participant	Designation
Mr. Sameer Hiremath	Vice Chairman and Managing Director
Mr. Kuldeep Jain	Chief Financial Officer
Mr. Manoj Mehrotra	President, Pharmaceuticals Business
Mr. Anish Swadi	Senior President, Business Transformation and Animal Health

Universal access for the call is available via +91 22 6280 1309 and +91 22 7115 8210. International toll-free numbers have also been provided for participants in Hong Kong, Singapore, the UK, and the USA. Investors can register for the Diamond Pass through a dedicated link.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.45%	+3.02%	+6.66%	-9.89%	-49.43%	-42.25%

Hikal Limited has announced a senior management change with the superannuation of Mr. Vimaldeep Kulshrestha, President-Crop Protection, effective April 14, 2026. The pharmaceutical and crop protection company disclosed this information to stock exchanges in compliance with regulatory requirements.

Management Transition Details

The company informed both BSE and NSE about Mr. Kulshrestha's superannuation through an official disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The announcement was signed by Rajasekhar Reddy, Company Secretary & Compliance Officer, on April 14, 2026.

Parameter	Details
Executive Name	Mr. Vimaldeep Kulshrestha
Position	President-Crop Protection
Reason for Change	Superannuation
Cessation Date	April 14, 2026

Regulatory Compliance

Hikal Limited's disclosure follows the requirements of SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The company provided comprehensive details in Annexure-A, outlining the specific circumstances of the management change. Mr. Kulshrestha will cease to be an employee from the end of business hours on the specified date.

Corporate Structure Impact

The superannuation represents a natural transition in Hikal's crop protection division leadership. As President-Crop Protection, Mr. Kulshrestha held a senior position within the company's agricultural solutions segment. The company has fulfilled its disclosure obligations by informing stakeholders about this senior management change through proper regulatory channels.

Hikal Limited operates from its registered office at Maker Chambers-5, Nariman Point, Mumbai, with administrative operations based in CBD Belapur, Navi Mumbai. The company continues its business operations across pharmaceutical and crop protection segments following this management transition.